Related Experiment Videos
[Mycobacterium avium complex infections: the point on the treatments]
S Brandissou1, B Hamel, B Veillet
1Laboratoire de Pharmacocinétique, CHU Carémeau, Nimes, France.
Abstract:
Mycobacterium avium complex (MAC) infections are the most frequent opportunistic infections in AIDS. Since progress in antiretroviral drugs enables AIDS patients to survive longer, these infections involve an increasing number of sick people. Few controlled assays have evaluated the efficiency of several antibiotics. When used in monotherapy, clarithromycin (one gram twice a day) appeared as the most efficient drug while the effectiveness of azithromycin, clofazimine, rifampin and liposomal encapsulated gentamicin have not been truly proved. Due to its bacteriologic and clinical effects, the most interesting polytherapeutic scheme is the association of clarithromycin (1 g twice a day), ethambutol (15 mg per kg and per day) and rifabutin (600 mg per day).
Insights
Clarithromycin monotherapy is effective for Mycobacterium avium complex (MAC) infections in AIDS patients. Combination therapy with clarithromycin, ethambutol, and rifabutin shows promising bacteriologic and clinical effects.
Area of Science:
- Infectious Diseases
- Immunology
- Pharmacology
Background:
- Mycobacterium avium complex (MAC) infections are common opportunistic infections in individuals with Acquired Immunodeficiency Syndrome (AIDS).
- Advancements in antiretroviral therapy have increased survival rates for AIDS patients, leading to a rise in MAC infections among this population.
- Limited controlled studies exist on the efficacy of various antibiotic treatments for MAC infections.
Purpose of the Study:
- To evaluate the effectiveness of different antibiotic treatments for Mycobacterium avium complex (MAC) infections.
- To identify the most effective monotherapy and combination therapy regimens for managing MAC infections in AIDS patients.
Main Methods:
- Review of controlled assays evaluating antibiotic efficacy for MAC infections.
- Comparison of monotherapy treatments including clarithromycin, azithromycin, clofazimine, rifampin, and liposomal encapsulated gentamicin.
- Assessment of a specific poly(or combination) therapy regimen: clarithromycin, ethambutol, and rifabutin.
Main Results:
- Clarithromycin, administered as one gram twice daily, demonstrated the highest efficacy in monotherapy.
- The effectiveness of azithromycin, clofazimine, rifampin, and liposomal encapsulated gentamicin as monotherapies was not conclusively proven.
- A combination therapy of clarithromycin (1 g twice daily), ethambutol (15 mg/kg/day), and rifabutin (600 mg/day) exhibited significant bacteriologic and clinical benefits.
Conclusions:
- Clarithromycin is the most effective single-agent antibiotic for treating MAC infections in AIDS patients.
- Combination therapy involving clarithromycin, ethambutol, and rifabutin is a highly effective treatment strategy for MAC infections, supported by its bacteriologic and clinical outcomes.